CERAVE DEVELOPED WITH DERMATOLOGISTS PSORIASIS MOISTURIZING- salicylic acid cream 
L'Oreal USA Products Inc

Disclaimer: Most OTC drugs are not reviewed and approved by FDA, however they may be marketed if they comply with applicable regulations and policies. FDA has not evaluated whether this product complies.

----------

Drug Facts

Active ingredient

Salicylic acid 2%

Purpose

Psoriasis

Uses

  • for the relief of skin itching, scaling, redness, flaking and irritation associated with psoriasis
  • helps prevent the recurrence of the symptoms of psoriasis

Warnings

For external use only

When using this product

avoid contact with the eyes. If contact occurs, rinse eyes thoroughly with water.

Stop use and ask a doctor if

condition worsens or does not improve after regular use of this product as directed

Ask doctor before use if

condition covers a large area of the body

Keep out of reach of children.

If swallowed, get medical help or contact a Poison Control Center right away.

Directions

apply to affected area one to four times daily or as directed by a doctor

Other information

  • keep cap tightly closed when not in use
  • store in cool, dry location

Inactive ingredients

water, urea, glyceryl stearate SE, cetearyl alcohol, butyrospermum parkii (shea) butter, glycerin, cetyl alcohol, niacinamide, laureth-9, limnanthes alba (meadowfoam) seed oil, PEG-100 stearate, gossypium herbaceum (cotton) seed oil, behentrimonium methosulfate, 1,2-hexanediol, C12-13 alkyl lactate, dimethicone, tasmannia lanceolata fruit/leaf extract, ceramide 3, ceamide 6-II, ceramide 1, phytosphingosine, cholesterol, tocopherol, hydroxyacetophenone, hydrogenated olive oil, glyceryl stearate, disodium EDTA, sodium lauroyl lactylate, xanthan gum, carbomer, sodium hyaluronate, sodium hydroxide

Questions or comments?

Toll-free number 1-888-768-2915

image of a label

CERAVE DEVELOPED WITH DERMATOLOGISTS PSORIASIS MOISTURIZING 
salicylic acid cream
Product Information
Product TypeHUMAN OTC DRUGItem Code (Source)NDC:49967-701
Route of AdministrationTOPICAL
Active Ingredient/Active Moiety
Ingredient NameBasis of StrengthStrength
SALICYLIC ACID (UNII: O414PZ4LPZ) (SALICYLIC ACID - UNII:O414PZ4LPZ) SALICYLIC ACID20 mg  in 1 g
Inactive Ingredients
Ingredient NameStrength
WATER (UNII: 059QF0KO0R)  
UREA (UNII: 8W8T17847W)  
GLYCERYL STEARATE SE (UNII: FCZ5MH785I)  
CETOSTEARYL ALCOHOL (UNII: 2DMT128M1S)  
NIACINAMIDE (UNII: 25X51I8RD4)  
POLIDOCANOL (UNII: 0AWH8BFG9A)  
MEADOWFOAM SEED OIL (UNII: 412ZHA4T4Y)  
PEG-100 STEARATE (UNII: YD01N1999R)  
LEVANT COTTONSEED OIL (UNII: N5CFT140R8)  
BEHENTRIMONIUM METHOSULFATE (UNII: 5SHP745C61)  
1,2-HEXANEDIOL (UNII: TR046Y3K1G)  
C12-13 ALKYL LACTATE (UNII: 9GLX7JL13M)  
DIMETHICONE (UNII: 92RU3N3Y1O)  
CERAMIDE 3 (UNII: 4370DF050B)  
CERAMIDE 6 II (UNII: F1X8L2B00J)  
CERAMIDE 1 (UNII: 5THT33P7X7)  
PHYTOSPHINGOSINE (UNII: GIN46U9Q2Q)  
CHOLESTEROL (UNII: 97C5T2UQ7J)  
TOCOPHEROL (UNII: R0ZB2556P8)  
HYDROXYACETOPHENONE (UNII: G1L3HT4CMH)  
HYDROGENATED OLIVE OIL (UNII: 53839415GI)  
GLYCERYL MONOSTEARATE (UNII: 230OU9XXE4)  
DISODIUM EDTA-COPPER (UNII: 6V475AX06U)  
SODIUM LAUROYL LACTYLATE (UNII: 7243K85WFO)  
XANTHAN GUM (UNII: TTV12P4NEE)  
CARBOMER HOMOPOLYMER TYPE B (ALLYL SUCROSE CROSSLINKED) (UNII: Z135WT9208)  
HYALURONATE SODIUM (UNII: YSE9PPT4TH)  
SODIUM HYDROXIDE (UNII: 55X04QC32I)  
Packaging
#Item CodePackage DescriptionMarketing Start DateMarketing End Date
1NDC:49967-701-01227 g in 1 JAR; Type 0: Not a Combination Product08/30/2017
2NDC:49967-701-025 g in 1 JAR; Type 1: Convenience Kit of Co-Package08/30/2017
Marketing Information
Marketing CategoryApplication Number or Monograph CitationMarketing Start DateMarketing End Date
OTC monograph finalpart358H08/30/2017
Labeler - L'Oreal USA Products Inc (002136794)
Establishment
NameAddressID/FEIBusiness Operations
Accupac, Inc.071609663manufacture(49967-701)
Establishment
NameAddressID/FEIBusiness Operations
L'OREAL USA PRODUCTS, INC624244349manufacture(49967-701) , pack(49967-701)

Revised: 1/2022
 
L'Oreal USA Products Inc